Journals / JAREM / 2018 / Cilt: 18 - Sayı: 3

Chronic Bacterial Prostatitis in a Turkish Population: The Microbiological Etiology and Distribution

Türk Toplumundaki Kronik Bakteriyel Prostatitin Etiyolojisi

Journal
JAREM
Pages
153–156
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This ratio is consistent with the NIHclassification

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the category 2 frequency and microorganism distribution of patients diagnosed with chronic prostatitis in a Turkishpopulation.Methods: Data of 3200 patients diagnosed with chronic prostatitis in the urology outpatient clinic between 2009 and 2014 were retrospectivelyreviewed.
📊
Key Findings & Data:The symptom scores were calculated considering the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI)according to pain (0-21 points), quality of life (0-12 points), and urinary (0-10 points) subdomains to a total score of 0-43 points.
💡
Conclusion & Impact:This ratio is consistent with the NIHclassification
🔬Design:Review & Systematic Survey
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the category 2 frequency and microorganism distribution of patients diagnosed with chronic prostatitis in a Turkishpopulation.Methods: Data of 3200 patients diagnosed with chronic prostatitis in the urology outpatient clinic between 2009 and 2014 were retrospectivelyreviewed. The symptom scores were calculated considering the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI)according to pain (0-21 points), quality of life (0-12 points), and urinary (0-10 points) subdomains to a total score of 0-43 points. All patients werechecked for symptoms, urinalysis, expressed prostatic secretion (EPS), or urine after prostatic massage (VB3) culture and PCR (Polymerase ChainReaction) of EPS or VB3 for Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, Mycoplasma genitalium, and Trichomonasvaginalis.Results: The mean age of the patients was calculated as 37.7±7.4 (range 22-65) years. The average of total NIH-CPSI score was determinedas 9.08 (range 1-40). In 223 of 3200 patients, positive culture and/or PCR results were observed. The results were as follows: E. coli 27 (12.1%),E. faecalis 18 (8.1%), S. epidermidis 15 (6.7%), S. haemolyticus 10 (4.5%), S. aureus 5 (2.2%), S. agalactiae 4 (1.8%), Pseudomonas 3 (1.3%), C.trachomatis 24 (10.8%), U. urealyticum 95 (42.6%), M. genitalium 6 (2.7%), M. hominis 14 (6.3%), and T. vaginalis 2 (0.9%).Conclusion: In a Turkish population, category 2 patients constitute 7% of all chronic prostatitis patients. This ratio is consistent with the NIHclassification

Özet

Amaç: Türk toplumunda kronik prostatit tanısı alan hastalarda kategori iki sıklığı ve mikroorganizma dağılımlarını araştırmayı amaçladık. Yöntemler: Üroloji polikliniğinde 2009-2014 yılları arasında kronik prostatit tanısı alan 3200 hastanın verileri retrospektif olarak incelendi. Tüm hastaların semptom skorları, Ulusal Sağlık Enstitüleri -Kronik Prostatit Semptom Indeksi (NIH-CPSI) ile toplam 43 puan üzerinden hesaplandı: ağrı (0-21 puan), yaşam kalitesi (0-12 puan), üriner (0-10 puan). Tüm hastalar üriner sistem semptomları, idrar analizi, prostat sekresyonu (EPS) veya VB3 kültürü ve C. trachomatis, U. urealyticum, M. hominis, M. genitalia açısından da EPS ve VB3’ün PCR sonuçları ile incelendi. Bulgular: Ortalama hasta yaşı 37,7±7,4 (dağılım 22-65), toplam NIH-CPSI skor ortalaması 9,08 (dağılım 1-40) olarak bulundu. 3200 hastanın 223'ünde pozitif kültür ve/veya müspet PCR sonucu elde edildi. Buna göre, kronik prostatit kategori iki sıklığı %7 olarak bulundu. Ortaya çıkan sonuçlara göre üreyen patojenlerin sırası ve dağlımı; E. coli 27 (%12,1), E. faecalis 18 (%8,1), S. epidermidis 15 (%6,7), S. hemolyticus 10 (%4,5), S. aureus 5 (%2,2), S. agalactiae 4 (%1,8), Pseudomonas 3 (%1,3), C. trachomatis 24 (%10,8) U. urealyticum 95 (%42,6), M. genitalia 6 (%2,7), M. hominis 14 (%6,3) ve T. vaginalis 2 (%0,9) şeklindedir. Sonuç: Türk toplumunda kronik prostatitli hastaların %7’sini kategori iki oluşturmakta olup Ulusal Sağlık Enstitüleri -Kronik Prostatit verileri ile örtüşmekte ancak en çok üreyen patojenlerin çalışmamızda U. urealyticum, E. coli ve C. trachomatis olması ile bu verilerden farklılık göstermektedir.

🔖

Cite This Article

ARDA, E., ÇAKIROĞLU, B., GÖZÜKÜÇÜK, R., ARIKAN, M. G. (2022). Chronic Bacterial Prostatitis in a Turkish Population: The Microbiological Etiology and Distribution. JAREM, Cilt: 18 - Sayı: 3, 153–156. https://ajindex.com/articles/558239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Arda E, Cakiroglu B, Tas T, Ekici S, Uyanik BS. Use of the UPOINT Classification in Turkish Chronic Prostatitis or Chronic Pelvic Pain Syndrome Patients. Urology 2016
  2. [CrossRef] 2. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968
  3. Collins MM, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998
  4. [CrossRef] 4. Bartoletti R, Cai T, Mondaini N, Dinelli N, Pinzi N, Pavone C, et al. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol 2007
  5. [CrossRef] 5. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998
  6. [CrossRef] 6. Skerk V, Krhen I, Schonwald S, Cajic V, Markovinovic L, Roglic S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004
  7. 24 Suppl 1: S53-6. [CrossRef] 7. Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents 1999
  8. [CrossRef] 8. Choi YS, Kim KS, Choi SW, Kim S, Bae WJ, Cho HJ, et al. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate Int 2013
  9. [CrossRef] 9. Dogan AN, Cakiroglu B, Hazar AI, Gozukucuk R, Uyanik BS. Can red cell distribution width and mean platelet volume serve as a marker for chronic prostatitis? Int J Clin Exp Med 2016
  10. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999
  11. [CrossRef] 11. Giubilei G, Mondaini N, Crisci A, Raugei A, Lombardi G, Travaglini F, Del Popolo G, Bartoletti R. The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol 2005
  12. [CrossRef] 12. Krieger J. Prostatitis, epididymitis and orchitis. 6th ed. Philadelphia: Elseivier’s Health Sciences
  13. Stevermer JJ, Easley SK. Treatment of prostatitis. Am Fam Physician 2000
  14. 22, 3025-6. 14. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE, Jr., Zeitlin S, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass te